CEACAM1 modulates epidermal growth factor receptor-mediated cell proliferation

Journal of Clinical Investigation

Volumn 114, Issue 7, 2004, Pages 944-952

  Abou Rjaily, George A ^a   Sang, Jun Lee ^a   May, Denisa ^b   Al Share, Qusai Y ^a   DeAngelis, Anthony M ^a   Ruch, Randall J ^a   Neumaier, Michael ^c   Kalthoff, Holger ^d   Lin, Sue Hwa ^e   Najjar, Sonia M ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b Ivonex GmbH   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; RAS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CARCINOEMBRYONIC ANTIGEN; CELL ADHESION MOLECULES; CELL DIVISION; CELL LINE, TUMOR; COS CELLS; HUMANS; INSULIN; LIVER; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, TRANSGENIC; OBESITY; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS;

EID: 9644270398     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200421786     Document Type: Article

References (59)

1. Blenis, J. 1993. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. U. S. A. 90:5889-5892.
2. Crews, C.M., and Erikson, R.L. 1993. Extracellular signals and reversible protein phosphorylation: what to Mek of it all. Cell. 74:215-217.
3. Cantley, L.C. 2002. The phosphoinositide 3-kinase pathway [review]. Science. 296:1655-1657.
4. Sadekova, S., Lamarche-Vane, N., Li, X., and Beauchemin, N. 2000. The CEACAM1-L glycoprotein associates with the actin cytoskeleton and localizes to cell-cell contact through activation of Rho-like GTPases. Mol. Biol. Cell. 11:65-77.
5. Wagener, C., and Ergun, S. 2000. Angiogenic properties of the carcinoembryonic antigen-related cell adhesion molecule. Exp. Cell Res. 261:19-24.
6. Najjar, S.M., et al. 1993. pp120/ecto-ATPase, an endogenous substrate of the insulin receptor tyrosine kinase, is expressed as two variably spliced isoforms. J. Biol. Chem. 268:1201-1206.
7. Najjar, S.M., et al. 1995. Insulin-stimulated phosphorylation of recombinant pp1120/HA4, an endogenous substrate of the insulin receptor tyrosine kinase. Biochemistry. 34:9341-9349.
8. Huber, M., et al. 1999. The carboxy-terminal region of biliary glycoprotein controls its tyrosine phosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cells. J. Biol. Chem. 274:335-344.
9. Poy, M.N., et al. 2002. CEACAM1 regulates insulin clearance in liver. Nat. Genet. 30:270-276.
10. Neumaier, M., et al. 1993. Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc. Natl. Acad. Sci. U. S. A. 90:10744-10748.
11. Thompson, N.L., Lin, S.H., Panzica, M.A., and Hixson, D.C. 1994. Cell CAM 105 isoform RNA expression is differentially regulated during rat liver regeneration and carcinogenesis. Pathobiology. 62:209-220.
12. Brummer, J., Neumaier, M., Gopfert, C., and Wagener, C. 1995. Association of pp60c-src with biliary glycoprotein (CD66a), an adhesion molecule of the carcinoembryonic antigen family downregulated in colorectal carcinomas. Oncogene. 11:1649-1655.
13. Turbide, C., Kunath, T., Daniels, E., and Beauchemin, N. 1997. Optimal ratios of biliary glycoprotein isoforms required for inhibition of colonic tumor cell growth. Cancer Res. 57:2781-2788.
14. Huang, J., et al. 1998. Expression of biliary glycoprotein (CD66a) in normal and malignant breast epithelial cells. Anticancer. 18:3203-3212.
15. Phan, D., et al. 2004. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res. 64:3072-3078.
16. Kunath, T., Ordonez-Garcia, C., Turbide, C., and Beauchemin, N. 1995. Inhibition of colonic tumor cell growth by biliary glycoprotein. Oncogene. 11:2375-2382.
17. Hsieh, J.-T., et al. 1995. Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. Cancer Res. 55:190-197.
18. Kleinerman, D.I., et al. 1996. Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model. Cancer Res. 56:3431-3425.
19. Luo, W., Wood, C.G., Earley, K., Hung, M.C., and Lin, S.H. 1997. Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domains. Oncogene. 14:1697-1704.
20. Soni, P., Lakkis, M., Poy, M.N., Fernstrom, M.A., and Najjar, S.M. 2000. The differential effects of pp 120 (Ceacam 1) on the mitogenic action of insulin and insulin-like growth factor 1 are regulated by the nonconserved tyrosine 1316 in the insulin receptor. Mol. Cell. Biol. 20:3896-3905.
21. Poy, M.N., Ruch, R.J., Fernström, M.A., Okabayashi, Y., and Najjar, S.M. 2002. Shc and CEACAM1 interact to regulate the mitogenic action of insulin. J. Biol. Chem. 277:1076-1084.
22. Singer, B.B., Scheffrahn, I., and Obrink, B. 2000. The tumor growth-inhibiting cell adhesion molecule CEACAM 1 (C-CAM) is differently expressed in proliferating and quiescent epithelial cells and regulates cell proliferation. Cancer Res. 60:1236-1244.
23. Estrera, V.T., Chen, D.T., Luo, W., Hixson, D.C., and Lin, S.-H. 2001. Signal transduction by the CEACAM1 tumor suppressor. Phosphorylation of serine 503 is required for growth-inhibitory activity. J. Biol. Chem. 276:15547-15553.
24. Lui, V.W., and Grandis, J.R. 2002. EGFR-mediated cell cycle regulation. Anticancer Res. 22:1-11.
25. Formisano, P., et al. 1995. Receptor-mediated internalization of insulin. Potential role of pp120/HA4, a substrate of the insulin receptor kinase. J. Biol. Chem. 270:24073-24077.
26. Li Calzi, S., Choice, C.V., and Najjar, S.M. 1997. Differential effect of pp120 on insulin endocytosis by two variant insulin receptor isoforms. Am. J. Physiol. 273:E801-E808.
27. Choice, C.V., Howard, M.J., Poy, M.N., Hankin, M.H., and Najjar, S.M. 1998. Insulin stimulates pp 120 endocytosis in cells co-expressing insulin receptors. J. Biol. Chem. 273:22194-22200.
28. Najjar, S.M., Choice, C.V., Soni, P., Whitman, C.M., and Poy, M.N. 1998. Effect of pp120 on receptor-mediated insulin endocytosis is regulated by the juxtamembrane domain of the insulin receptor. J. Biol. Chem. 273:12923-12928.
29. Baldeweg, S.E., et al. 2000. Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). Eur. J. Clin. Invest. 30:45-52.
30. Bays, H., Mandarino, L., and DeFronzo, R.A. 2004. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach [review]. J. Clin. Endocrinol. Metab. 89:463-478.
31. Lewis, G.F., Carpentier, A., Adeli, K., and Giacca, A. 2002. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocrinol. Rev. 23:201-229.
32. Groop, L.C., Bonadonna, R.C., Shank, M., Petrides, A.S., and DeFronzo, R.A. 1991. Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J. Clin. Invest. 87:83-89.
33. Calle, E.E., Rodriguez, C., Walker-Thurmond, K., and Thun, M.J. 2003. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl J. Med. 348:1625-1638.
34. Harvie, M., Hooper, L., and Howell, A.H. 2003. Central obesity and breast cancer risk: a systematic review. Obes. Rev. 4:157-173.
35. Baldwin, S., and Parker, R.S. 1986. The effects of dietary fat and selenium on the development of preneoplastic lesions in rat liver. Nutr. Cancer. 8:273-282.
36. Connolly, J.M., Liu, X.H., and Rose, D.P. 1997. Effects of dietary menhaden oil, soy, and a cyclooxygenase inhibitor on human breast cancer cell growth and metastasis in nude mice. Nutr. Cancer. 29:48-54.
37. Hardy, R.W., Wickramasinghe, N.S., Ke, S.C., and Wells, A. 1997. Fatty acids and breast cancer cell proliferation [review]. Adv. Exp. Med. Biol. 422:57-69.
38. Mollerup, S., and Haugen, A. 1996. Differential effect of polyunsaturated fatty acids on cell proliferation during human epithelial in vitro carcinogenesis: involvement of epidermal growth factor receptor tyrosine kinase. Br. J. Cancer. 74:613-618.
39. Dulin, N.O., Sorokin, A., and Douglas, J.G. 1998. Arachidonate-induced tyrosine phosphorylation of epidermal growth factor receptor and Shc-Grb2-Sos association. Hypertension. 32:1089-1093.
40. Vacaresse, N., et al. 1999. Activation of epithelial growth factor receptor pathway by unsaturated fatty acids. Circ. Res. 85:892-899.
41. Wells, A. 1999. EGF receptor. Int. J. Biochem. Cell Biol. 31:637-643.
42. Cowing, B.E., and Saker, K.E. 2001. Polyunsaturated fatty acids and epidermal growth factor receptor/mitogen-activated protein kinase signaling in mammary cancer [review]. J. Nutr. 131:1125-1128.
43. Hajri, T., Han, X.X., Bonen, A., and Abumrad, N.A. 2002. Defective fatty acid uptake modulates insulin responsiveness and metabolic tesponses to diet in CD36-null mice. J. Clin. Invest. 109:1381-1389. doi:10.1172/200214596.
44. Hegarty, B.D., Cooney, G.J., Kraegen, B.W., and Furler, S.M. 2002. Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes. 51:1477-1484.
45. Higashiyama, S., Abraham, J.A., Miller, J., Fiddes, J.C., and Klagsbrun, M. 1991. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science. 251:836-939.
46. Phillips, S.A., Perrotti, N., and Taylor, S.I. 1987. Rat liver membranes contain a 120 kDa glycoprotein which serves as a substrate for the tyrosine kinases of the receptors for insulin and epidermal growth factor. FEBS Lett. 212:141-144.
47. Fahlgren, A., et al. 2003. Interferon-gamma tempers the expression of carcinoembryonic antigen family molecules in human colon cells: a possible role in innate mucosal defence. Scand J. Immunol. 58:628-641.
48. Accili, D., Kido, Y., Nakae, J., Lauro, D., and Park, B.-C. 2001. Genetics of type 2 diabetes: insights from targeted mouse mutants. Curr. Mol. Med. 1:9-23.
49. Kiso, S., et al. 2003. Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy. Gastroenterology. 124:701-707.
50. Jackson, L.F., et al. 2003. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J. 22:2704-2716.
51. Koeffler, H.P. 2003. Peroxisome proliferator-activated receptor gamma and cancers. Clin. Cancer Res. 9:1-9.
52. Wang, M., Vogel, I., and Kalthoff, H. 2003. Correlation between metastacic potential and variants from colorectal tumor cell line HT-29. World J. Gastroenterol. 9:2627-2631.
53. Carter, R.E., and Sorkin, A. 1998. Endocytosis of functional epidermal growth factor receptor-green fluorescent protein chimera. J Biol. Chem. 273:35000-35007.
54. Kleinerman, D.I., et al. 1995. Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study. Cancer Res. 55:2831-2836.
55. Fry, D.W., et al. 1998. Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. Proc. Natl. Acad. Sci. U. S. A. 95:12022-12027.
56. Schmiegel, W.H., et al. 1985. Monoclonal antibody-defined human pancreatic cancer-associated antigens. Cancer Res. 45:1402-1407.
57. Wagener, C., Clark, B.R., Rickard, K.J., and Shively, J.E. 1983. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay. J. Immunol. 130:2302-2307.
58. Lee, S.J., Sung, J.H., Lee, S.J., Moon, C.K., and Lee, B.H. 1999. Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett. 144:39-43.
59. Steinbrecher, K.A., Wowk, S.A., Rudolph, J.A., Witte, D.P., and Cohen, M.B. 2002. Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation. Am J. Pathol. 161:2169-2178.